Special Issue "Protein Biomarkers"
Deadline for manuscript submissions: 28 February 2019
Prof. Dr. Giovanni Cuda
Universita degli studi Magna Graecia di Catanzaro, Department of Experimental and Clinical Medicine, Catanzaro, Italy
Website | E-Mail
Interests: Clinical proteomics (biomarkers discovery and validation on human tissues and biofluids); Stem cell research, with a specific focus on induced pluripotent stem cells (iPSCs) as a model for complex diseases.
In the last few years, proteomic profiling technologies have had a tremendous impact on the diagnosis, management and follow-up of many human diseases. These approaches have provided new information that integrates the transcriptional profiling picture, adding, at the same time, a new level of complexity. Recently, the low molecular weight proteome obtained from plasma/serum has drawn the attention of the scientific community as a rapidly emerging frontier for protein biomarker discovery. At the same time, proteomic analysis may allow the detection of molecular changes correlated to drug response in preclinical models. These changes can be detected in the whole cell proteome, as well as in specific cell compartments or in functionally related groups of proteins. Relevant changes can also be detected in the secreted proteins, which might in some way be paralleled by changes detected in the serum proteome.
The present Special Issue aims to provide an update on protein biomarker discovery, with a special focus on the most recent and advanced proteomic technologies.
Prof. Dr. Giovanni Cuda
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Molecules is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1800 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- Protein Biomarkers
- Mass Spectrometry
- 2D-Gel Electrophoresis
- Induced Pluripotent Stem Cells
- Human Disease Modelling